Beyond weight loss: the expanding benefits of GLP-1 receptor agonists
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) were introduced to help manage type 2 diabetes. They improve glycemic control and promote weight loss, which we all know are essential for long-term outcomes. In practice, I’ve seen that their impact goes beyond these traditional targets. Patients often benefit from cardiovascular protection and kidney improvements, and emerging data show advantages in areas we did not initially anticipate, such as sleep apnea, joint health, …
Beyond weight loss: the expanding benefits of GLP-1 receptor agonists










![Simple choices prevent chronic disease [PODCAST]](https://kevinmd.com/wp-content/uploads/Design-1-1-190x100.jpg)